renal or cardiac disorders in Japan. In: 32nd International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 2016 August 25-28; Dublin Ireland. Pharmacoepidemiol Drug Saf 25 (Suppl 3), 26 [...] results of a long-term study program [abstract]. In: 32nd Int Conf on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), Dublin, Aug 25 – 28, 2016; Pharmacoepidemiol Drug Saf 25 (Suppl 3), 496 [...] Diabetes Patients and Matched Controls. In: 32nd International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 2016 August 25-28; Dublin Ireland. Pharmacoepidemiol Drug Saf 25 (Suppl 3), 69
Effects on temporomandibular disorder in the treatment of tension-type headache with acupuncture and therapeutic exercises. A secondary analysis from a randomized controlled trial. Clinical Rehabilitation 2024;
NAKAMURA M: Bilateral sphenoorbital hyperostotic meningiomas with proptosis and visual impairment. a therapeutic challenge. Clinical Neurology and Neurosurgery 113:859-863, 2011. GHAEMI K, MIRZAYAN MJ, KRAUSS [...] G, ESMAEILZADEH M, HARTMANN C, HERMANN EJ, KRAUSS JK. Multiple desmoplastic infantile gliomas-therapeutic challenges. Childs Nerv Syst. 2016 Jan;32(1):17. BAUMERT BG, HEGI ME, VAN DEN BENT MJ, VON DEIMLING [...] HOLTKAMP N. Impaired Pten expression in malignant peripheral nerve sheath tumours and implication for therapeutic intervention with mTOR inhibitors. PLoS One. 2012;7(11):e47595. CAMPOS B, WARTA R, CHAISAINGMONGKOL
10th July 2015 Silvia Gramolelli Research Topic: The PLCγ/calcineurin/NFAT pathway as a novel therapeutic target for Kaposi Sarcoma Herpesvirus-induced aberrant angiogenesis Supervisor: Prof. Dr. Thomas [...] School, Germany Christian Stern Research Topic: Tumor targeting of filamentous phages displaying therapeutic molecules by bacterial carriers Supervisor: Dr. Siegfried Weiß, Department of Molecular Immunology
PMID: 38217849. (Review) Garbers C , Werfel T (2024). Important molecular differences between therapeutic IL-6 receptor inhibition and its genetic mimicry in patients with AD. J Allergy Clin Immunol. 2024 [...] (2024). Polysialic acid-Siglec immune checkpoints of microglia and macrophages: perspectives for therapeutic intervention. Neural Regen Res. 2024 Dec 16. doi: 10.4103/NRR.NRR-D-24-01195. Online ahead of print [...] on the article 'Patents in the Diabetes Area in the Years 2008-2016'. (2018), Expert opinion on therapeutic patents 28 (3) 173-174 Litschko C. , Oldrini D., Budde I. , Berger M ., Meens J., Gerardy-Schahn
Davenport, Colin F.. 2022. Publisher's page Novel aspects of regulatory T cell dysfunction as a therapeutic target in giant cell arteritis Adriawan, Ignatius Ryan, Atschekzei, Faranaz, Dittrich-Breiholz [...] non-structural membrane protein K15 is required for viral lytic replication and may represent a therapeutic target Abere, Bizunesh, Mamo, Tamrat M., Hartmann, Silke, Samarina, Naira, Hage, Elias, Rückert
PubMed Identification of galectin-3 as a novel potential prognostic/predictive biomarker and therapeutic target for cerebral cavernous malformation disease, Souvik Kar, Andrea Perrelli, Kiran Kumar Bali
Araúzo-Bravo MJ, Vondran FWR , Cantz T, Horscroft N, Balakrishnan A, Chevessier F, Ott M, Sharma AD. Therapeutic HNF4A mRNA attenuates liver fibrosis in a preclinical model. J Hepatol. 2021 Dec;75(6):1420-1433 [...] Seeliger B, Schmidt JJ, Wiesner O, Schmidt BMW, Taubert R, Vondran FWR , Hoeper MM, David S. Therapeutic plasma exchange in acute on chronic liver failure. J Clin Apher. 2020 Aug;35(4):316-327. doi: 10
1119363 Adeno-Associated Virus Vector Design-Moving the Adeno-Associated Virus to a Bioengineered Therapeutic Nanoparticle. Jäschke N, Büning H. Hematol Oncol Clin North Am 2022;36(4):667-685 DOI: 10.1016/j
Wollert, K. C., Gohla, A., Katus, H. A., Muller, O. J., Bauersachs, J., and Heineke, J. 2019. A gene therapeutic approach to inhibit calcium and integrin binding protein 1 ameliorates maladaptive remodelling [...] products. Adv Drug Deliv Rev 120:108. https://doi.org/10.1016/j.addr.2017.09.004 . Martin, U. 2017. Therapeutic Application of Pluripotent Stem Cells: Challenges and Risks. Front Med (Lausanne) 4:229. https://doi